首页> 外文期刊>The Journal of biological chemistry >Human DNA Polymerase β Mutations Allowing Efficient Abasic Site Bypass
【24h】

Human DNA Polymerase β Mutations Allowing Efficient Abasic Site Bypass

机译:人DNA聚合酶β突变允许有效的脱脂部位旁路

获取原文

摘要

The DNA of every cell in the human body gets damaged more than 50,000 times a day. The most frequent damages are abasic sites. This kind of damage blocks proceeding DNA synthesis by several DNA polymerases that are involved in DNA replication and repair. The mechanistic basis for the incapability of these DNA polymerases to bypass abasic sites is not clarified. To gain insights into the mechanistic basis, we intended to identify amino acid residues that govern for the pausing of DNA polymerase β when incorporating a nucleotide opposite to abasic sites. Human DNA polymerase β was chosen because it is a well characterized DNA polymerase and serves as model enzyme for studies of DNA polymerase mechanisms. Moreover, it acts as the main gap-filling enzyme in base excision repair, and human tumor studies suggest a link between DNA polymerase β and cancer. In this study we employed high throughput screening of a library of more than 11,000 human DNA polymerase β variants. We identified two mutants that have increased ability to incorporate a nucleotide opposite to an abasic site. We found that the substitutions E232K and T233I promote incorporation opposite the lesion. In addition to this feature, the variants have an increased activity and a lower fidelity when processing nondamaged DNA. The mutations described in this work are located in well characterized regions but have not been reported before. A crystallographic structure of one of the mutants was obtained, providing structural insights.
机译:人体中每种细胞的DNA每天受损超过50,000次。最常见的损害赔偿位点。这种损伤块通过参与DNA复制和修复的几种DNA聚合酶进行DNA合成。不澄清这些DNA聚合酶以旁路脱脂位点的无法释放的机械基础。为了进入机械基础,我们旨在鉴定治理用于纳入DNA聚合酶β的氨基酸残基,当将核苷酸纳入与释放位点相对的核苷酸时。选择人DNA聚合酶β,因为它是一种良好表征的DNA聚合酶,并用作用于研究DNA聚合酶机制的模型酶。此外,它用作基本切除修复中的主要间隙填充酶,人肿瘤研究表明DNA聚合酶β和癌症之间的联系。在这项研究中,我们使用高于11,000名人DNA聚合酶β变体的文库的高通量筛选。我们鉴定了两个具有增加的核苷酸能力的突变体,该突变体能够与Abasic位点相对的核苷酸。我们发现替代E232K和T233I促进了损伤对面的掺入。除了该特征之外,当处理非均多DNA时,变体在加工时具有增加的活性和较低的保真度。本作作品中描述的突变位于特征在于特征的区域,但尚未以前则报告。获得其中一种突变体的晶体结构,提供结构见解。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号